Gillanders Arbuthnot & Company Ltd. (GILLANDERS): Gillanders Arbuthnot & Company Share Price Rises 11.31% Today

Gillanders Arbuthnot & Company Ltd. rose to Rs 99.89, up 11.31% today, taking its market capitalisation to Rs 189.95 crore.

Gillanders Arbuthnot & Company Share Price moved sharply higher on 17 August 2026, with the stock rising 11.31% to Rs 99.89 from the previous close of Rs 89.74. With a market capitalisation of Rs 189.95 crore, the company falls in the Micro Cap category, making this single-session move notable in today’s Stock Market Today context. The gain also places the stock among the top gainers today in its segment, even though the supplied data does not establish a company-specific catalyst behind the move.

For investors tracking Gillanders Arbuthnot & Company Share Price Today, the price action was straightforward and strong on the day’s tape. The stock opened at Rs 89.73, also the day’s low, and climbed to Rs 99.89, which was the day’s high as well. That means the share price rise developed through the session without slipping below the opening level, a pattern that naturally draws attention in Stocks in News and Market Movers screens.

Gillanders Arbuthnot & Company Stock News is also relevant because the move came alongside total traded volume of 2,360 shares, including 27 shares on BSE and 2,333 shares on NSE, while reported turnover stood at Rs 0 crore. From a fundamental angle, the stock is trading at a P/E ratio of 10.89 and a P/B ratio of 0.73, with ROE at 6.25%, ROCE at 7.46% and EPS at Rs 8.17. Investors now have a clear set of numbers to monitor next: price behaviour after today’s rise, valuation relative to peers, and whether profitability metrics continue to justify closer attention on Univest.

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 99.89
Previous Close	Rs 89.74
Today's Change	+Rs 10.15 (+11.31%)
Day Open	Rs 89.73
Day High	Rs 99.89
Day Low	Rs 89.73
Current Volume (BSE)	27
BSE Traded Volume	27
NSE Traded Volume	2,333
Combined NSE + BSE Volume	2,360
Turnover	Rs 0 crore
Market Capitalisation	Rs 189.95 crore
Market Cap Category	Micro Cap

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) traded at Rs 99.89. versus the previous close of Rs 89.74, a rise of 11.31%. The stock opened at Rs 89.73, reached Rs 99.89, touched Rs 89.73. Reported volume was 27.

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 189.95 crore
P/E Ratio	10.89x
P/B Ratio	0.73x
ROE	6.25%
ROCE	7.46%
EPS	Rs 8.17
Dividend Yield	0%

Gillanders Arbuthnot & Company Ltd. was valued at a P/E ratio of 10.89x, a P/B ratio of 0.73x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 6.25% and ROCE of 7.46%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 8.17, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Gillanders Arbuthnot & Company Fundamental Analysis shows a micro-cap stock with moderate profitability metrics, a relatively modest earnings multiple and a below-1 price-to-book valuation. At Rs 189.95 crore in market capitalisation, the company is small in size, which can make price moves more pronounced, but market cap alone does not define business quality. The more useful context comes from valuation and return ratios.

Profitability is positive, though not exceptionally high. Return on equity stands at 6.25%, indicating the company generated 6.25% returns on shareholder equity. Return on capital employed is 7.46%, giving another lens on capital efficiency across the operating base. EPS is Rs 8.17, which is important because earnings per share provide the denominator for the P/E calculation and anchor today’s stock analysis in reported profitability rather than only price action.

Dividend yield is 0. That tells investors the stock does not currently offer a historical or current payout yield on the supplied data, so the present market focus is more likely tied to price movement and valuation than income distribution. Put together, Gillanders Arbuthnot & Company Share Price appears supported by positive earnings, a P/E of 10.89, a P/B of 0.73, ROE of 6.25%, ROCE of 7.46% and EPS of Rs 8.17. Those numbers do not establish why the stock is rising today, but they do provide a factual framework for why the move is worth tracking more closely on Univest.

Sector and Industry Context

Metric	Value
Sector	Diversified
Industry	Diversified
Benchmark Scope	same industry
Company P/E Ratio	10.89x
Benchmark Median P/E	15.43x
Benchmark Average P/E	55.02x
Benchmark P/E Range	10.61x to 334.7x
Company P/B Ratio	0.73x
Benchmark Median P/B	1.26x
Company ROE	6.25%
Benchmark Median ROE	5.75%
Company ROCE	7.46%
Benchmark Median ROCE	7.82%
Company Market Capitalisation	Rs 189.95 crore
Benchmark Median Market Cap	Rs 92.64 crore

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) is classified under sector: Diversified and industry: Diversified.

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) has a P/E ratio of 10.89x, which is below the benchmark median of 15.43x, a difference of -29.42%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) has a ROE of 6.25%, which is above the benchmark median of 5.75%, a difference of +8.7%. Gillanders Arbuthnot & Company Ltd. (GILLANDERS) has a ROCE of 7.46%, which is below the benchmark median of 7.82%, a difference of -4.6%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Gillanders Arbuthnot & Company operates in the Diversified sector and Diversified industry, and the supplied benchmark compares it with the same industry across 14 companies. On this basis, the stock’s valuation and profitability can be read against a wider group rather than in isolation.

Within the sector snapshot, the company’s P/E ratio of 10.89 sits below the industry median of 15.43 and well below the industry average of 55.02. The benchmark P/E range runs from 10.61 to 334.7 across 8 companies with available P/E data. That places Gillanders Arbuthnot & Company near the lower end of the observed earnings-multiple range, only slightly above the minimum of 10.61. On price-to-book, the company’s P/B ratio of 0.73 is below the industry median of 1.26 and also below the average of 3.63 across 14 companies, in a range stretching from -0.07 to 31.44.

Profitability presents a more mixed picture. The company’s ROE of 6.25% is above the benchmark median ROE of 5.75% and also above the benchmark average of -14.07, though that average is clearly influenced by deeply negative outliers within the industry set. ROCE at 7.46% is below the industry median of 7.82% but above the average of 3.76. That means the company is not an extreme outperformer on capital efficiency, yet it is not lagging the broader average either.

Market-cap context matters too. Gillanders Arbuthnot & Company’s market capitalisation of Rs 189.95 crore is above the sector median of Rs 92.64 crore but below the average of Rs 539.46 crore. The industry market-cap range spans from Rs 4.51 crore to Rs 2,960.93 crore. In other words, the stock sits above the middle of the micro and smaller diversified pack, but well below the largest listed names. For Univest readers, that combination of lower-end valuation and moderate profitability helps explain why the stock can enter the conversation when a strong one-day price rise appears.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Balmer Lawrie & Company Ltd.	BALMLAWRIE	2,960.93	10.61	1.39	5.34	8.19
TTK Healthcare Ltd.	TTKHLTCARE	1,639.68	22.17	1.45	6.02	8.59
Kothari Industrial Corporation Ltd.	KOTIC	1,585.76	0	6.76	0	0
Empire Industries Ltd.	EMPIND	650.37	11.59	1.85	5.49	9.47
Aspinwall And Company Ltd.	ASPINWALL	184.51	11.73	0.92	10.33	12.4

Gillanders Arbuthnot & Company Ltd. (GILLANDERS) has a P/E ratio of 10.89x compared with the displayed peer median of 11.59x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 6.25% compares with a peer median of 5.49% across the companies shown in the table. ROCE stood at 7.46% versus the displayed peer median of 8.59%, providing a capital-efficiency comparison. Gillanders Arbuthnot & Company Ltd. (GILLANDERS) has a market capitalisation of Rs 189.95 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Gillanders Arbuthnot & Company Share Price looks most interesting in peer comparison because its valuation is relatively restrained when placed beside several listed diversified names. Among the supplied peers, Balmer Lawrie & Company Ltd. trades at a P/E of 10.61, very close to Gillanders Arbuthnot’s 10.89, while Empire Industries Ltd. is at 11.59 and Aspinwall And Company Ltd. at 11.73. ANI Integrated Services Ltd. and Krypton Industries Ltd. trade higher at 19.38 and 19.13 respectively, while TTK Healthcare Ltd. is at 22.17. TCI Industries Ltd. stands out at 334.7, making the peer range unusually wide.

On market capitalisation, Gillanders Arbuthnot at Rs 189.95 crore is much smaller than Balmer Lawrie at Rs 2,960.93 crore, TTK Healthcare at Rs 1,639.68 crore, Kothari Industrial Corporation at Rs 1,585.76 crore and Empire Industries at Rs 650.37 crore. It is, however, slightly larger than Aspinwall at Rs 184.51 crore and notably larger than ANI Integrated Services at Rs 67.79 crore, Indrayani Biotech at Rs 61.36 crore and Krypton Industries at Rs 53.38 crore.

Profitability ratios also show a balanced but not dominant position. Gillanders Arbuthnot’s ROE of 6.25% is above Balmer Lawrie’s 5.34%, TTK Healthcare’s 6.02%, Empire Industries’ 5.49% and Kothari Industrial Corporation’s 0, but below Aspinwall’s 10.33%, ANI Integrated Services’ 11.71% and Krypton’s 6.65%. ROCE at 7.46% is below Balmer Lawrie’s 8.19%, TTK Healthcare’s 8.59%, Empire’s 9.47%, Aspinwall’s 12.4%, ANI’s 11 and Krypton’s 9.5%, but ahead of Kothari’s 0 and TCI Industries’ -10.9. This suggests Gillanders Arbuthnot & Company Stock Analysis is less about standout profitability and more about a combination of measured valuation and today’s visible price action.

Why Investors Are Watching Gillanders Arbuthnot & Company

Investors are watching this stock because today’s move was large enough to place it among the session’s top gainers, while the underlying valuation and sector comparison provide additional context. Gillanders Arbuthnot & Company Share Price is not moving in a vacuum; it now sits at the intersection of micro-cap price action, reasonable earnings valuation and mixed-but-positive profitability ratios.

• Price action: The stock rose 11.31%, from Rs 89.74 to Rs 99.89, with the day open and low both at Rs 89.73 and the day high equal to the current price.
• Volume: Total traded volume stood at 2,360 shares, split between 27 shares on BSE and 2,333 shares on NSE.
• Valuation: P/E is 10.89 and P/B is 0.73, both below the relevant industry median figures of 15.43 and 1.26.
• Profitability: ROE of 6.25% is above the industry median of 5.75%, while ROCE of 7.46% is slightly below the median of 7.82%.
• Sector position: Market capitalisation of Rs 189.95 crore is above the industry median of Rs 92.64 crore.

What investors should monitor next is whether Gillanders Arbuthnot & Company Share Price holds near the day’s high after such a sharp one-session rise, and whether subsequent trading continues to reflect interest beyond a single spike. On Univest, that means tracking the next few sessions’ price behaviour, valuation versus peers and whether the stock continues to feature in daily stock updates.

About Gillanders Arbuthnot & Company

Gillanders Arbuthnot & Company Ltd. is classified in the Diversified sector and Diversified industry in the supplied market dataset. That label matters because diversified businesses are typically assessed through a wider valuation lens than pure-play sector companies, and peer comparisons can show broad differences in earnings multiples, capital efficiency and market scale.

Within its listed industry set, Gillanders Arbuthnot & Company is neither among the very largest nor the very smallest names. Its market capitalisation of Rs 189.95 crore places it above the industry median of Rs 92.64 crore, but well below the upper end represented by Balmer Lawrie & Company Ltd. at Rs 2,960.93 crore and TTK Healthcare Ltd. at Rs 1,639.68 crore. That positioning is useful because it frames the company as a smaller listed diversified player rather than a sector heavyweight.

The supplied data set for Gillanders Arbuthnot & Company Share Price does not include business-segment or revenue-mix details, so the clearest verified company context comes from its market positioning and financial profile. Those figures show a business trading on a P/E ratio of 10.89 and a P/B ratio of 0.73, while delivering ROE of 6.25%, ROCE of 7.46% and EPS of Rs 8.17. In practical terms, the market is currently valuing the company at less than book value and at a moderate earnings multiple within its industry band. That is why Gillanders Arbuthnot & Company Latest News is being read not just as a price event, but also as a stock analysis story.

Track Gillanders Arbuthnot & Company Share Price on Univest

Use Gillanders Arbuthnot & Company Ltd. (GILLANDERS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Readers who want to follow Gillanders Arbuthnot & Company Share Price more closely can track it on Univest for live share price updates, market capitalisation changes and day-by-day stock performance. Univest also helps investors monitor key ratios such as P/E, P/B, ROE, ROCE, EPS and dividend yield in one place, alongside 52-week level tracking and broader market insights.

For traders and long-term market observers alike, Univest can be useful for following Gillanders Arbuthnot & Company Share Price Today across BSE and NSE activity, checking whether the stock remains in top gainer lists, and comparing the company with peers in the diversified industry. That makes Univest relevant not as a recommendation platform here, but as a research and tracking tool for verified stock updates.

Frequently Asked Questions

Why is Gillanders Arbuthnot & Company Share Price rising today?

Ans. Gillanders Arbuthnot & Company Share Price rose because the stock gained 11.31% in the session, moving from the previous close of Rs 89.74 to Rs 99.89. The supplied data confirms the price event, but it does not establish a company-specific.

What is Gillanders Arbuthnot & Company Share Price Today?

Ans. Gillanders Arbuthnot & Company Share Price Today is Rs 99.89. The stock opened at Rs 89.73, touched a low of Rs 89.73 and a high of Rs 99.89, showing that the latest quoted price was also the session high.

How much did Gillanders Arbuthnot & Company stock gain today?

Ans. The stock gained Rs 10.15 in absolute terms and 11.31% in percentage terms during the session. That move lifted the price from Rs 89.74 to Rs 99.89 and put the micro-cap stock among today’s notable gainers.

What does today’s intraday price action show?

Ans. Today’s price action shows a session that began at Rs 89.73, which was also the day’s low, and climbed to Rs 99.89, which was also the day’s high. That pattern suggests sustained upward movement through the trading session.

What is the market capitalisation of Gillanders Arbuthnot & Company?

Ans. The company’s market capitalisation is Rs 189.95 crore. In the supplied classification, it falls under the Micro Cap category, which is important because sharp single-day moves in smaller companies often attract closer market attention.

Is Gillanders Arbuthnot & Company expensive based on current valuation data?

Ans. On the supplied numbers, the stock trades at a P/E of 10.89 and a P/B of 0.73. Both are below the same-industry median levels of 15.43 and 1.26 respectively, indicating a lower valuation than the benchmark median.

How profitable is Gillanders Arbuthnot & Company on the supplied ratios?

Ans. The company has ROE of 6.25% and ROCE of 7.46%. Its ROE is above the industry median of 5.75%, while its ROCE is slightly below the industry median of 7.82%, giving a mixed but positive profitability picture.

What is the EPS and dividend yield of Gillanders Arbuthnot & Company?

Ans. EPS stands at Rs 8.17, which reflects earnings attributable to each share on the supplied data. Dividend yield is 0, indicating there is no current or historical yield contribution in the present market snapshot.

What should investors monitor after this price rise?

Ans. Investors can monitor whether the stock holds near Rs 99.89 after today’s 11.31% rise, how volume develops after total traded shares of 2,360, and whether valuation and profitability metrics continue to compare reasonably with industry peers.